Correction: Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells (Cell Death & Disease, (2022), 13, 2, (114), 10.1038/s41419-022-04572-8)

Sharon J. Manley, Appolinaire A. Olou, Jarrid L. Jack, Mariana T. Ruckert, R. Mc Kinnon Walsh, Austin E. Eades, Bailey A. Bye, Joe Ambrose, Fanuel Messaggio, Shrikant Anant, Michael N. VanSaun

Research output: Contribution to journalComment/debatepeer-review

Abstract

The original version of this article unfortunately needed to be updated. A related file was included as supplementary and the author would like it removed. The original article has been corrected.

Original languageEnglish (US)
Article number165
JournalCell Death and Disease
Volume13
Issue number2
DOIs
StatePublished - Feb 2022
Externally publishedYes

ASJC Scopus subject areas

  • Immunology
  • Cellular and Molecular Neuroscience
  • Cell Biology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction: Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells (Cell Death & Disease, (2022), 13, 2, (114), 10.1038/s41419-022-04572-8)'. Together they form a unique fingerprint.

Cite this